Ligand Pharmaceuticals Incorporated(LGND)
$107.14▲1.07%
Market is closed - opens 7 PM, 29 Jul 2024
Insights
- Ligand Pharmaceuticals Incorporated is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Ligand Pharmaceuticals Incorporated stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Ligand Pharmaceuticals Incorporated stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Ligand Pharmaceuticals Incorporated stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 76.61 | Sell |
Stochastic | 87.78, 90.1 | Sell |
Ultimate Oscillator | 55.76 | Neutral |
Stochastic Relative Strength Index | 83.85, 78.9 | Neutral |
Moving Average Convergence Divergence | 5.5, 4.65 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 100.76 | Buy |
20 | 94.19 | Buy |
50 | 87.45 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 100.27 | Buy |
20 | 95.72 | Buy |
50 | 88.77 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 100.7 | Buy |
20 | 93.47 | Buy |
50 | 87.99 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 105.02 | Buy |
20 | 102.79 | Buy |
50 | 96.08 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 105.31 | Sell |
20 | 105.59 | Buy |
50 | 100.02 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 108.88 |
Resistance L2 | 107.12 |
Resistance L1 | 105.03 |
Pivot Point | 103.27 |
Support L1 | 101.18 |
Support L2 | 99.42 |
Support L3 | 97.33 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.